Notify me when Kathleen D. Scott files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Chief Financial Officer | $302,017 | -$892,665 | -75% | 02 Jan 2026 |
| DRMA, DRMAW | Dermata Therapeutics, Inc. | Director | 02 Jan 2026 | |||
| NKGN, NKGNW | NKGen Biotech, Inc. | Director | 06 Dec 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|